Skip to main content
Zumtobel Group AG logo

Zumtobel Group AG — Investor Relations & Filings

Ticker · ZAG ISIN · AT0000837307 LEI · 529900IIODYNYAZ2ID26 VI Manufacturing
Open in API
Filings indexed 689 across all filing types
Latest filing 2025-01-31 Transaction in Own Shar…
Country AT Austria
Listing VI ZAG

About Zumtobel Group AG

https://z.lighting/en/

Zumtobel Group AG is an international provider of integral lighting solutions for professional applications. The company develops, manufactures, and markets a comprehensive portfolio of products and services, including high-quality LED luminaires, lighting components, and sophisticated lighting management systems. Its offerings encompass both hardware and software, focusing on innovation, quality, and design to create tailored solutions for a wide range of professional indoor and outdoor environments. The group provides complete lighting systems designed to enhance well-being and energy efficiency.

Recent filings

Filing Released Lang Actions
PTA-CMS: Beendigung des Rückkaufprogramms zum Erwerb eigener Aktien der Zumtobel Group AG
Transaction in Own Shares Classification · 100% confidence The document explicitly announces the 'Beendigung des Rückkaufprogramms zum Erwerb eigener Aktien' (Termination of the share repurchase program) by Zumtobel Group AG. It details the total volume acquired (808,945 shares), the percentage of share capital held (1.87%), and provides a transaction log for the final days of the program. This content directly relates to the company buying back or selling its own shares, which corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), an interim report (IR), or a full annual report (10-K).
2025-01-31 German
PTA-CMS: Share buyback – 59th Interim Report
Transaction in Own Shares Classification · 100% confidence The document explicitly states it is the "59th Interim Report" regarding the "Share buyback" program. It details specific transactions, including the volume of shares repurchased, prices, and total value, executed between January 20 and January 24, 2025. The keywords "stock transaction of own shares" and the detailed table reporting repurchases directly map to the definition of a Transaction in Own Shares (POS). This is a report of the activity, not just an announcement of a report's publication.
2025-01-28 English
PTA-CMS: Erwerb eigener Aktien – 59. Zwischenmeldung
Transaction in Own Shares Classification · 100% confidence The document explicitly states it is the '59. Zwischenmeldung' (59th Interim Report/Notification) regarding the 'Erwerb eigener Aktien' (Acquisition of own shares) under the share buyback program, referencing MAR and EU regulations. The content is a detailed table showing daily transactions (volume, price range, total value) for the period January 20 to January 24, 2025. This type of regular disclosure concerning the company buying back its own stock is specifically classified as 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a general earnings release (ER) or interim report (IR).
2025-01-28 German
PTA-Adhoc: Approval of cessation of production at ZG Europhane / Update to inside information from 16 October 2024
Regulatory Filings Classification · 100% confidence The document is a public disclosure of inside information according to Article 17 of the Market Abuse Regulation (MAR). It announces a specific strategic decision (cessation of production at a plant) and provides financial impact estimates. This type of announcement, which deals with material, non-public information that could significantly affect the share price, is typically classified as a general regulatory filing or an announcement related to corporate actions/material events. Since it is not a standard financial report (10-K, IR, ER), a management discussion (MDA), or a specific shareholder action (DIV, DVA), and it is a direct disclosure mandated by regulation, it fits best under the general 'Regulatory Filings' category (RNS) as a fallback, or potentially 'LTR' if it were a legal proceeding, but here it is a strategic operational update disclosed under MAR. Given the options, RNS is the most appropriate catch-all for mandatory, non-standard regulatory disclosures like this MAR announcement.
2025-01-24 English
PTA-Adhoc: Genehmigung der Einstellung des Produktionsbetriebes der ZG Europhane / Aktualisierung Insiderinformation vom 16.10.2024
Management Reports Classification · 99% confidence The document is an official announcement dated January 24, 2025, referencing a prior Ad hoc Mitteilung (insider information) from October 16, 2024, regarding the approval to cease production at a subsidiary (ZG Europhane). It details the impact (84 employees, EUR 10M special effects) and confirms a final decision by the Board. This type of material, which reports significant, non-public strategic decisions affecting the company's operations and financial outlook, falls under the category of mandatory disclosure, often related to material events. Since it is an update on a major strategic decision (plant closure) and involves financial implications, it is a significant corporate event disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard quarterly report (IR). Given the context of mandatory disclosure of material non-public information (Art 17 MAR), and the nature of the strategic operational change, it best fits the general category for significant regulatory announcements that aren't specifically covered by other codes like DIV or DIRS. However, since it is a specific update on a major operational/strategic decision, and not just a general regulatory filing, we must check the definitions. It is not a merger (TAR), financing (CAP), or management change (MANG). It is a significant operational/strategic update. In the absence of a specific 'Strategic Update' code, and given that it is a formal disclosure of material information (Art 17 MAR), it functions as a regulatory announcement. If it were a full management discussion, it would be MDA, but this is a specific event announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for significant, non-standard regulatory disclosures that don't fit the other specific financial/governance codes, although it strongly resembles an Ad Hoc disclosure which often precedes or is part of an ER/IR/10-K filing. Since it is a specific, material, non-routine announcement, RNS is the best fit among the provided codes for a general regulatory disclosure.
2025-01-24 German
PTA-CMS: Share buyback – 58th Interim Report
Transaction in Own Shares Classification · 100% confidence The document is a report detailing the specific transactions of a share buyback program (repurchase of own shares) by Zumtobel Group AG, including dates, volumes, and prices. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-01-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.